INDV
Indivior Pharmaceuticals, Inc.
35.80$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 81.9% | 84.8% | 85.9% | 82.3% | 77.5% | 78.8% | 71.2% | 71.7% | 63.6% | 54.2% | |
| 57.2% | 59.8% | 59.7% | 64.2% | 56.0% | 60.2% | 43.8% | 17.9% | 24.2% | 16.2% | |
| 57.2% | 59.8% | 59.7% | 64.2% | 56.0% | 60.2% | 50.5% | 23.2% | 24.3% | 16.2% | |
| 17.0% | 17.8% | 18.0% | 12.3% | 14.3% | 11.0% | 12.4% | 14.4% | 19.3% | 21.2% | |
| 3.4% | 3.6% | 5.0% | 4.4% | 6.1% | 5.2% | 6.4% | 7.6% | 13.5% | 12.7% | |
| – | – | – | 6.5% | 6.7% | 5.2% | 4.8% | – | – | – | |
| – | – | – | – | – | 0.0% | 0.0% | 0.3% | 0.2% | 0.2% | |
| – | – | – | 4.4% | 4.0% | 4.5% | 3.9% | 0.7% | 0.4% | 0.2% | |
| 124.4% | 114.1% | 95.7% | 87.3% | 94.6% | 88.9% | 97.1% | 110.8% | 126.4% | 108.1% | |
| 85.2% | 59.1% | 52.9% | 44.9% | 39.1% | 43.9% | 57.6% | 73.1% | 71.2% | 75.9% | |
| 8.4% | 0.3% | 0.3% | 0.5% | 0.8% | 0.6% | 0.6% | 0.7% | 2.1% | 3.2% | |
| 2.7% | 2.8% | 3.0% | 30.2% | 27.2% | 1.4% | 1.9% | 2.2% | 4.8% | 4.0% | |
| – | – | – | 14.1% | 15.0% | 13.0% | 13.3% | 13.4% | 23.9% | 24.1% | |
| -24.4% | -14.1% | 4.3% | 12.7% | 5.4% | 11.1% | 2.9% | -10.8% | -26.4% | -8.1% | |
| 78.6% | 71.5% | 85.0% | 87.7% | 85.6% | 78.5% | 73.7% | -16.7% | -34.4% | -20.2% | |
| 12.3% | 10.4% | 9.7% | 9.1% | 9.6% | 8.4% | 7.8% | 8.0% | 10.1% | 10.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.